BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6712767)

  • 1. The binding of human aortic glycosaminoglycans and proteoglycans to plasma low density lipoproteins.
    Mourão PA; Bracamonte CA
    Atherosclerosis; 1984 Feb; 50(2):133-46. PubMed ID: 6712767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of high molecular weight chondroitin sulfate from human aorta with plasma low density lipoproteins.
    Alves CS; Mourão PA
    Atherosclerosis; 1988 Oct; 73(2-3):113-24. PubMed ID: 3142491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in populations of aortic glycosaminoglycans: species with low affinity for plasma low-density lipoproteins, and not species with high affinity, are preferentially affected.
    Tovar AM; Cesar DC; Leta GC; Mourão PA
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):604-14. PubMed ID: 9580254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins.
    Leta GC; Mourão PA; Tovar AM
    Biochim Biophys Acta; 2002 Apr; 1586(3):243-53. PubMed ID: 11997076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of chondroitin 6-sulfate to plasma low density lipoprotein.
    Mourão PA; Pillai S; Di Ferrante N
    Biochim Biophys Acta; 1981 May; 674(2):178-87. PubMed ID: 6786361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoprotein binding affinity of arterial wall isomeric chondroitin sulfate proteoglycans.
    Srinivasan SR; Vijayagopal P; Eberle K; Dalferes ER; Radhakrishnamurthy B; Berenson GS
    Atherosclerosis; 1988 Jul; 72(1):1-9. PubMed ID: 3214455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL.
    Cardoso LE; Mourão PA
    Arterioscler Thromb; 1994 Jan; 14(1):115-24. PubMed ID: 8274466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction.
    Srinivasan SR; Vijayagopal P; Eberle K; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1989 Nov; 1006(2):159-66. PubMed ID: 2512982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
    Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
    J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.
    Hurt-Camejo E; Camejo G; Rosengren B; López F; Ahlström C; Fager G; Bondjers G
    Arterioscler Thromb; 1992 May; 12(5):569-83. PubMed ID: 1576119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of serum lipoproteins and a proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    J Biol Chem; 1981 Aug; 256(15):8234-41. PubMed ID: 7263647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor, present in plasma, inhibiting the interaction of low density lipoprotein with arterial proteoglycan.
    Kempen HJ; Buytenhek M; Gruber E; Bihari-Varga M
    Atherosclerosis; 1989 Aug; 78(2-3):137-44. PubMed ID: 2783198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional modifications of human aorta proteoglycans in atherosclerosis.
    Cherchi GM; Coinu R; Demuro P; Formato M; Sanna G; Tidore M; Tira ME; De Luca G
    Matrix; 1990 Dec; 10(6):362-72. PubMed ID: 2084515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein lipase enhances the interaction of low density lipoproteins with artery-derived extracellular matrix proteoglycans.
    Edwards IJ; Goldberg IJ; Parks JS; Xu H; Wagner WD
    J Lipid Res; 1993 Jul; 34(7):1155-63. PubMed ID: 8371063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein binding affinity of arterial chondroitin sulfate proteoglycan variants modulates cholesteryl ester accumulation in macrophages.
    Srinivasan SR; Xu JH; Vijayagopal P; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1995 Aug; 1272(1):61-7. PubMed ID: 7662721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of the low density lipoprotein-glycosaminoglycan interaction.
    Sambandam T; Baker JR; Christner JE; Ekborg SL
    Arterioscler Thromb; 1991; 11(3):561-8. PubMed ID: 2029496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties.
    Chang MY; Potter-Perigo S; Tsoi C; Chait A; Wight TN
    J Biol Chem; 2000 Feb; 275(7):4766-73. PubMed ID: 10671509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the interaction between plasma proteoglycans and LDL by means of fluorescence spectroscopy].
    Siddi F; Senes A; Coinu R; Formato M; Cherchi GM
    Boll Soc Ital Biol Sper; 1992 Nov; 68(11):655-61. PubMed ID: 1297360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein.
    Kaplan M; Aviram M
    Atherosclerosis; 2000 Mar; 149(1):5-17. PubMed ID: 10704609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.